A federal judge dismissed a case brought by unions against Bristol-Myers Squibb alleging that coupons for the drugmaker's antipsychotic Abilify amounted to bribes and kickbacks that defrauded union health plans. However, the judge allowed the unions to refile lawsuits alleging that Bristol-Myers misrepresented benchmark prices. The unions say such discounts increase health insurance premiums by encouraging the use of expensive branded drugs over less-expensive alternatives.

Full Story:

Related Summaries